Skip to main content

Table 3 Demographic and clinical data of patients with AAT deficiency

From: Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD

 

PIMZ

PIMS

PIMI

Total

N

3

1

2

6

Age (years) ÷ mean (SD)

59(16.9)

62

51(2)

56.8(12.7)

Male %

33.3

100

50

50

BMI (kg/m2) ÷ mean (SD)

22.7(0,9)

18

25(2.5)

21.2(2.3)

FEV1/FVC ÷ mean (SD)

0.48(0.2)

0.34

0.48(0.02)

0.47(0.6)

FEV1% Predicted ÷ mean (SD)

46.5(2.1)

40

48.5(0.7)

48(4.5)

FVC(%) ÷ mean (SD)

51.3(4.05)

47

49.5(3.5)

2.9(0.2)

MRC (score) ÷ mean (SD)

2

3

2

2.3 (0.5)

CAT (score) ÷ mean (SD)

29.5(2.1)

40

34.5(6.3)

34.3 (9.9)

Current/former/non smoker (%)

0/33,3/0

0/0/0

50/0/0

16,6/16,6/0

Pack/year ÷ (years) mean (SD)

20

0

34

27(7)